Physician profile
Benjamin T Go
NPI 1982624946
$3,774.42
in general payments reported to CMS, 2019-2025
20 companies · $946 in 2025
The $946 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,317 · 2020: $231 · 2021: $127 · 2022: $533 · 2023: $135 · 2024: $485 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $850 · Food and Beverage: $616 · Education: $64.54 · Honoraria: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $850.00 |
| Food and Beverage | $616.17 |
| Education | $64.54 |
| Honoraria | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $850.00 | 2025 | Evis Exera III Duodenovideoscope |
| Cook Medical LLC | $747.20 | 2019-2024 | Instinct, Hemospray |
| Gilead Sciences, INC. | $425.89 | 2019-2022 | |
| Pfizer INC. | $277.86 | 2019-2024 | |
| Boston Scientific Corporation | $262.42 | 2022-2024 | Exalt Model D, Watchman Access System |
| Intercept Pharmaceuticals, INC. | $149.30 | 2019 | |
| Medtronic, INC. | $143.83 | 2021-2025 | Pillcam, Barrx, Endoflip |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2019 | |
| Apollo Endosurgery US INC | $121.51 | 2022 | |
| Eisai INC. | $100.65 | 2020 | |
| Olympus America INC. | $98.08 | 2020 | |
| Janssen Scientific Affairs, LLC | $96.48 | 2019 | |
| Mylan Specialty L.P. | $95.75 | 2019 | |
| Novo Nordisk INC | $64.54 | 2025 | |
| Erbe USA INC | $47.59 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $46.07 | 2020-2024 | Airsupra |
| Covidien Lp | $36.30 | 2019 | |
| W. L. Gore & Associates, INC. | $35.00 | 2024 | Gore Viabil Biliary Endoprosthesis |
| Abbvie INC. | $27.53 | 2024 | |
| Madrigal Pharmaceuticals | $23.44 | 2024 | Resmetirom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.